700 patients110,866 observations180 daysLIVE

Patient P-02522

Synthetic patientMETA-24 · Day 166 · 75+ · F · baseline S01Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S01
  2. Day 108 BR-03 recommendedBehavioural Recommendation BR-03
  3. Day 109 Patient acceptedStarted BR-03 in the companion
  4. Day 116 Trajectory diverged from predictionObserved response fell below the model's expected path.
  5. Day 116 No meaningful changeBehavioural Recommendation BR-03

What changed?

Trajectory began diverging from predicted response on Day 116.

Primary contributors, last 14 days
  • Nutritional resilience-8
  • Treatment adherence+3
  • GI instability+2

What helped?

  • Behavioural Recommendation BR-03Day 108
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
67 min
stable · -2.6 vs previous 14 d
Sleep duration
Wearable
5.9 h
stable · -0.0 vs previous 14 d
Energy level
Daily log
5.9/10
stable · +0.2 vs previous 14 d
Steps
Wearable
8,082
stable · -245 vs previous 14 d
GI burden
Companion
18.5/100
improving · -0.9 vs previous 14 d
Adherence
Companion
83.5 %
stable · -3.3 vs previous 14 d
Sleep quality
Wearable
42.6/100
stable · -0.2 vs previous 14 d
Glucose, CGM daily mean
CGM
130 mg/dL
stable · +1.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 70 from the failing basin, 38 from restoration.

Good elements to keep
  • Butyrate producers intact
    hidden · steering +7.5
  • Behavioural Recommendation BR-03
    intervention · steering +5
  • Protein (supports)
    perturbation · steering +4.9
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -2.8 next day
Main detractors to watch
  • FUT2 non-secretor
    hidden · steering -10.6
  • IL6 high-expression variant
    hidden · steering -7.3
  • Histamine load
    perturbation · steering -6.7
  • Alcohol
    perturbation · steering -6
  • Histamine load
    detractor · GI +3.9 next day
  • Alcohol
    detractor · GI +3.3 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Histamine load
    +3.9detractor · 95%
  • Alcohol
    +3.3detractor · 95%
  • Protein
    -2.8supporter · 85%
  • Simple carbohydrates
    -1.4no signal · 37%
  • Insoluble fibre
    +1.1no signal · 27%
  • Caffeine
    +1.1no signal · 30%
  • Ultra-processed food
    +0.9no signal · 31%
  • Dietary fat load
    +0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 70
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 5.9 h, below personal baseline
  • Inflammatory signalling 25
    • DNAIL6 -174 variant raises baseline inflammatory tone
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
  • GLP1R rs6923761 A
    Altered receptor sensitivity
Microbiome
Shannon diversity 3.9 · butyrate capacity 78/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
57 ms
Sleep
6.2 h
Steps
7,469
Resting HR
57 bpm
Daily log: GI score 19, nutritional resilience 66, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0208747%S01BR-03no change40
P-0237547%S0144
P-0204142%S0127
P-0243842%S0132
P-0226938%S0127
P-0221835%S01DT-01improved61
P-0263834%S01BR-03improved41
P-0227633%S0157
P-0256833%S0151
P-0268133%S0151
P-0221731%S0161
P-0243731%S0164